A pyroptosis nanotuner for cancer therapy

Area of Science:

• Biomedical Engineering
• Molecular Biology
• Oncology

Background:

• Pyroptosis, a form of programmed necrosis mediated by gasdermins, offers potential for cancer therapy but faces challenges in selectively targeting cancer cells.
• Inducing pyroptosis specifically in cancer cells while sparing healthy tissues remains a significant hurdle in developing effective cancer treatments.

Purpose of the Study:

• To engineer an acid-activatable nanophotosensitizer platform for spatiotemporally controlled pyroptosis.
• To investigate the role of endosomal maturation stages in modulating pyroptosis activity.
• To develop a tunable system for enhancing anti-tumor efficacy and reducing systemic side effects in cancer therapy.

Main Methods:

• Development of an acid-activatable nanophotosensitizer library.
• Targeting distinct stages of endosomal maturation (early endosomes vs. late endosomes/lysosomes).
• Activation of phospholipase C signaling transduction to trigger gasdermin-E-mediated pyroptosis.

Main Results:

• Demonstrated tunable pyroptosis induction with up to 40-fold control.
• Showcased reduced pyroptosis when nanophotosensitizers reached late endosomes/lysosomes.
• Achieved enhanced anti-tumor efficacy in gasdermin-E-positive human cancers with minimized systemic side effects.

Conclusions:

• The nanotuner platform enables precise control over pyroptosis through targeted endocytic signaling.
• This approach offers a promising strategy for developing nanomedicines with tunable pyroptosis for cancer therapy.
• The study provides insights into engineering nanomedicines for targeted cancer cell death.